[go: up one dir, main page]

AR006437A1 - USE OF N- MONOHYDROCHLORIDE (ENDO-9-METHYL-9-AZABICICLO [3.3.1] NON-3-IL) -1- METHYLIMIDAZOLE-3-CARBOXAMIDE, FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PROPHYLAXIS OF DIARRHEA AND A PHARMACEUTICAL COMPOSITION THAT CONTAINS IT - Google Patents

USE OF N- MONOHYDROCHLORIDE (ENDO-9-METHYL-9-AZABICICLO [3.3.1] NON-3-IL) -1- METHYLIMIDAZOLE-3-CARBOXAMIDE, FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PROPHYLAXIS OF DIARRHEA AND A PHARMACEUTICAL COMPOSITION THAT CONTAINS IT

Info

Publication number
AR006437A1
AR006437A1 ARP970101255A ARP970101255A AR006437A1 AR 006437 A1 AR006437 A1 AR 006437A1 AR P970101255 A ARP970101255 A AR P970101255A AR P970101255 A ARP970101255 A AR P970101255A AR 006437 A1 AR006437 A1 AR 006437A1
Authority
AR
Argentina
Prior art keywords
diarrhea
prophylaxis
manufacture
treatment
pharmaceutical composition
Prior art date
Application number
ARP970101255A
Other languages
Spanish (es)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR006437A1 publication Critical patent/AR006437A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El uso de granisetrón en la fabricación de un medicamento para el tratamiento o la profilaxis de diarrea y una composición farmacéutica que locontiene.The use of granisetron in the manufacture of a medicament for the treatment or prophylaxis of diarrhea and a pharmaceutical composition that contains it.

ARP970101255A 1996-03-29 1997-03-26 USE OF N- MONOHYDROCHLORIDE (ENDO-9-METHYL-9-AZABICICLO [3.3.1] NON-3-IL) -1- METHYLIMIDAZOLE-3-CARBOXAMIDE, FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PROPHYLAXIS OF DIARRHEA AND A PHARMACEUTICAL COMPOSITION THAT CONTAINS IT AR006437A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9606745.9A GB9606745D0 (en) 1996-03-29 1996-03-29 Pharmaceuticals

Publications (1)

Publication Number Publication Date
AR006437A1 true AR006437A1 (en) 1999-08-25

Family

ID=10791339

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970101255A AR006437A1 (en) 1996-03-29 1997-03-26 USE OF N- MONOHYDROCHLORIDE (ENDO-9-METHYL-9-AZABICICLO [3.3.1] NON-3-IL) -1- METHYLIMIDAZOLE-3-CARBOXAMIDE, FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PROPHYLAXIS OF DIARRHEA AND A PHARMACEUTICAL COMPOSITION THAT CONTAINS IT

Country Status (6)

Country Link
AR (1) AR006437A1 (en)
AU (1) AU2290597A (en)
CO (1) CO4790092A1 (en)
GB (1) GB9606745D0 (en)
WO (1) WO1997036586A1 (en)
ZA (1) ZA972684B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000048597A1 (en) * 1999-02-18 2000-08-24 Novartis Ag Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes

Also Published As

Publication number Publication date
CO4790092A1 (en) 1999-05-31
WO1997036586A1 (en) 1997-10-09
AU2290597A (en) 1997-10-22
GB9606745D0 (en) 1996-06-05
ZA972684B (en) 1998-09-28

Similar Documents

Publication Publication Date Title
MX9204268A (en) A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
MD960330A (en) Nonpeptidyl compounds, pharmaceutical composition on base thereof, treatment process
ATE224360T1 (en) ADAMANTAN DERIVATIVES
PT1036058E (en) ADAMANTAN DERIVATIVES
ES2156840T1 (en) MEDICINAL PRODUCT CONTAINING PENTOSANE POLYSULFATE AND IMPLANT TO TREAT FIBROSIS.
NO964966L (en) Lactobacillus strains of human origin, mixtures and their use
CO4290346A1 (en) Azithromycin Controlled Release Dosage Forms
ES2182357T3 (en) NEW USE OF BUDESONIDE AND FORMOTEROL.
FI962952L (en) Delta 12,13-iso-taxol analogues, their antineoplastic use and pharmaceutical compositions containing them
DE69932510D1 (en) VASKULARISIERUNGSINHIBITOREN
ES2172171T3 (en) MEDICINAL PRODUCT, CONTAINING YOHIMBINE AND ARGININE, FOR THE TREATMENT OF ERECTILE DYSFUNCTIONS.
DE69311541D1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING THE DEACYLATED GLYCEROPHOSPHOLIPIDES
TR199802351T2 (en) Anti-vaginitis composition containing one or more local anesthetics and anti-vaginitis agents for topical use.
ES2132556T3 (en) NEW DERIVATIVE OF BENZO-TIADIAZINA, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
MX9704034A (en) DERIVATIVES AND COMPOSITIONS OF SUBSTITUTED 2-ARYLCARBONYLOXYMETHYL-1,2,5-TIADIAZOLIDIN-3-ONA 1,1-DIOXIDE AND METHOD OF USE.
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
AR011437A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT.
MX9304185A (en) PRODUCT AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT FOR THE TREATMENT OF MASTITIS AND BOVINE MESTRITIS.
MX9405371A (en) NAFTILE DERIVATIVE.
ES2188611T3 (en) USE OF GRANISETRON FOR THE TREATMENT OF POST-OPERATIVE NAUSEAS AND VOMITES.
AR006437A1 (en) USE OF N- MONOHYDROCHLORIDE (ENDO-9-METHYL-9-AZABICICLO [3.3.1] NON-3-IL) -1- METHYLIMIDAZOLE-3-CARBOXAMIDE, FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PROPHYLAXIS OF DIARRHEA AND A PHARMACEUTICAL COMPOSITION THAT CONTAINS IT
CL2004001291A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES CARBOCICLIC AND HETEROCICLIC COMPOUNDS; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF INFLUENZA INFECTION.
ES2196769T3 (en) TOPICAL USE OF LOPERAMIDE FOR THE TREATMENT OF MICROBIAL INFECTIONS.
GR3019776T3 (en) Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof
ES2055421T3 (en) USE OF CLORMETIAZOLE IN THE MANUFACTURE OF A MEDICATION FOR THE PREVENTION AND / OR TREATMENT OF NEURODEGENERATION.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal